{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:32:41Z","timestamp":1759969961582,"version":"build-2065373602"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"First\u00a0Affiliated\u00a0Hospital\u00a0of\u00a0Harbin\u00a0Medical\u00a0University\u00a0Fund\u00a0for\u00a0Distinguished\u00a0Young Medical\u00a0Scholars","award":["2021J17"],"award-info":[{"award-number":["2021J17"]}]},{"name":"BEIJING MEDICAL AWARD FOUNDATION","award":["YXJL-2021-0302-0287"],"award-info":[{"award-number":["YXJL-2021-0302-0287"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03214-x","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:57:35Z","timestamp":1759917455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival analysis of metachronous bilateral ectopic breast cancer utilizing the SEER database and the pioneering construction of a nomogram model"],"prefix":"10.1186","volume":"30","author":[{"given":"Lizhi","family":"Teng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juntong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"1","key":"3214_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"1130","key":"3214_CR2","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20211033","volume":"95","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95(1130):20211033. https:\/\/doi.org\/10.1259\/bjr.20211033.","journal-title":"Br J Radiol"},{"issue":"1","key":"3214_CR3","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1186\/s12885-024-12822-5","volume":"24","author":"FG Dandena","year":"2024","unstructured":"Dandena FG, Teklewold BT, Darebo TD, Suga YD. Epidemiology and clinical characteristics of breast cancer in Ethiopia: a systematic review. BMC Cancer. 2024;24(1):1102. https:\/\/doi.org\/10.1186\/s12885-024-12822-5.","journal-title":"BMC Cancer"},{"issue":"12","key":"3214_CR4","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1038\/s41379-021-00890-y","volume":"34","author":"F Fei","year":"2021","unstructured":"Fei F, Zhang K, Siegal GP, Wei S. A simplified breast cancer prognostic score: comparison with the AJCC clinical prognostic staging system. Mod Pathol. 2021;34(12):2141\u20137. https:\/\/doi.org\/10.1038\/s41379-021-00890-y.","journal-title":"Mod Pathol"},{"issue":"2","key":"3214_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5152\/ejbh.2020.5297","volume":"16","author":"A Huber","year":"2020","unstructured":"Huber A, Seidler SJ, Huber DE. Clinicopathological characteristics, treatment and outcome of 123 patients with synchronous or metachronous bilateral breast cancer in a Swiss institutional retrospective series. Eur J Breast Health. 2020;16(2):129\u201336. https:\/\/doi.org\/10.5152\/ejbh.2020.5297.","journal-title":"Eur J Breast Health"},{"issue":"3","key":"3214_CR6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2325\/jbcs.12.196","volume":"12","author":"H Takahashi","year":"2005","unstructured":"Takahashi H, Watanabe K, Takahashi M, Taguchi K, Sasaki F, Todo S. The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer. Breast Cancer. 2005;12(3):196\u2013202. https:\/\/doi.org\/10.2325\/jbcs.12.196.","journal-title":"Breast Cancer"},{"issue":"2","key":"3214_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4103\/ijabmr.IJABMR_384_16","volume":"8","author":"A Singla","year":"2018","unstructured":"Singla A, Kaur N, Walia DS, Singla D. Bilateral metachronous breast carcinoma: a rare case report. Int J Appl Basic Med Res. 2018;8(2):126\u20138. https:\/\/doi.org\/10.4103\/ijabmr.IJABMR_384_16.","journal-title":"Int J Appl Basic Med Res"},{"key":"3214_CR8","doi-asserted-by":"publisher","first-page":"1034556","DOI":"10.3389\/fonc.2023.1034556","volume":"13","author":"N Abdullah","year":"2023","unstructured":"Abdullah N, Rizuana IH, Goh JHL, Lee QZ, Md Isa N, Md Pauzi SH. Bilateral metachronous breast malignancies: malignant phylloides and invasive breast carcinoma-a case report. Front Oncol. 2023;13:1034556. https:\/\/doi.org\/10.3389\/fonc.2023.1034556.","journal-title":"Front Oncol"},{"issue":"5","key":"3214_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s12282-024-01591-5","volume":"31","author":"L Teng","year":"2024","unstructured":"Teng L, Du J, Yan S, Xu P, Liu J, Zhao X, et al. A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database. Breast Cancer. 2024;31(5):769\u201386. https:\/\/doi.org\/10.1007\/s12282-024-01591-5.","journal-title":"Breast Cancer"},{"issue":"1","key":"3214_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12957-023-03030-9","volume":"21","author":"L Teng","year":"2023","unstructured":"Teng L, Yan S, Du J, Yang R, Xu P, Tao W. Clinicopathological analysis and prognostic treatment study of angiosarcoma of the breast: a SEER population-based analysis. World J Surg Oncol. 2023;21(1):144. https:\/\/doi.org\/10.1186\/s12957-023-03030-9.","journal-title":"World J Surg Oncol"},{"issue":"4","key":"3214_CR11","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/ije\/dyz274","volume":"49","author":"ACJW Janssens","year":"2020","unstructured":"Janssens ACJW, Martens FK. Reflection on modern methods: revisiting the area under the ROC curve. Int J Epidemiol. 2020;49(4):1397\u2013403. https:\/\/doi.org\/10.1093\/ije\/dyz274.","journal-title":"Int J Epidemiol"},{"key":"3214_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2019.07.008","volume":"92","author":"S Mruthyunjayappa","year":"2019","unstructured":"Mruthyunjayappa S, Zhang K, Zhang L, Eltoum IA, Siegal GP, Wei S. Synchronous and metachronous bilateral breast cancer: clinicopathologic characteristics and prognostic outcomes. Hum Pathol. 2019;92:1\u20139. https:\/\/doi.org\/10.1016\/j.humpath.2019.07.008.","journal-title":"Hum Pathol"},{"issue":"33","key":"3214_CR13","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1200\/JCO.2008.21.5756","volume":"27","author":"ME Brennan","year":"2009","unstructured":"Brennan ME, Houssami N, Lord S, Macaskill P, Irwig L, Dixon JM, et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol. 2009;27(33):5640\u20139. https:\/\/doi.org\/10.1200\/JCO.2008.21.5756.","journal-title":"J Clin Oncol"},{"issue":"10","key":"3214_CR14","first-page":"855","volume":"8","author":"Y Chen","year":"1999","unstructured":"Chen Y, Thompson W, Semenciw R, Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev. 1999;8(10):855\u201361.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"3214_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/ijc.31051","volume":"142","author":"CB Begg","year":"2018","unstructured":"Begg CB, Ostrovnaya I, Geyer FC, Papanastasiou AD, Ng CKY, Sakr RA, et al. Contralateral breast cancers: Independent cancers or metastases? Int J Cancer. 2018;142(2):347\u201356. https:\/\/doi.org\/10.1002\/ijc.31051.","journal-title":"Int J Cancer"},{"issue":"4","key":"3214_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.7326\/0003-4819-149-4-200808190-00010","volume":"149","author":"DA Grimes","year":"2008","unstructured":"Grimes DA. The nomogram epidemic: resurgence of a medical relic. Ann Intern Med. 2008;149(4):273\u20135. https:\/\/doi.org\/10.7326\/0003-4819-149-4-200808190-00010. (PMID: 18711159).","journal-title":"Ann Intern Med"},{"issue":"4","key":"3214_CR17","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u201380. https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7.","journal-title":"Lancet Oncol"},{"issue":"7","key":"3214_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ijsu.2013.05.005","volume":"11","author":"YL Kuo","year":"2013","unstructured":"Kuo YL, Chen WC, Yao WJ, Cheng L, Hsu HP, Lai HW, et al. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison. Int J Surg. 2013;11(7):538\u201343. https:\/\/doi.org\/10.1016\/j.ijsu.2013.05.005.","journal-title":"Int J Surg"},{"issue":"27","key":"3214_CR19","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1200\/JCO.2006.10.5056","volume":"25","author":"M Hartman","year":"2007","unstructured":"Hartman M, Czene K, Reilly M, Adolfsson J, Bergh J, Adami HO, et al. Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol. 2007;25(27):4210\u20136. https:\/\/doi.org\/10.1200\/JCO.2006.10.5056.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3214_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/sj.bjc.6601042","volume":"89","author":"CI Li","year":"2003","unstructured":"Li CI, Malone KE, Porter PL, Daling JR. Epidemiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer. 2003;89(3):513\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6601042.","journal-title":"Br J Cancer"},{"issue":"2","key":"3214_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1245\/s10434-023-14451-x","volume":"31","author":"AK Schulze","year":"2024","unstructured":"Schulze AK, Hoskin TL, Moldoveanu D, Sturz JL, Boughey JC. Tumor characteristics of bilateral breast cancer compared with unilateral breast cancer. Ann Surg Oncol. 2024;31(2):947\u201356. https:\/\/doi.org\/10.1245\/s10434-023-14451-x.","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"3214_CR22","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402\u201316. https:\/\/doi.org\/10.1001\/jama.2017.7112.","journal-title":"JAMA"},{"issue":"1","key":"3214_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12282-020-01146-4","volume":"28","author":"H Zhao","year":"2021","unstructured":"Zhao H. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast. Breast Cancer. 2021;28(1):187\u201395. https:\/\/doi.org\/10.1007\/s12282-020-01146-4.","journal-title":"Breast Cancer"},{"issue":"1","key":"3214_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10549-022-06532-4","volume":"194","author":"MA Mallory","year":"2022","unstructured":"Mallory MA, Whiting K, Park A, G\u00f6nen M, Gilbert E, King TA, et al. Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ. Breast Cancer Res Treat. 2022;194(1):137\u201348. https:\/\/doi.org\/10.1007\/s10549-022-06532-4.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3214_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10549-015-3538-5","volume":"153","author":"JJ Jobsen","year":"2015","unstructured":"Jobsen JJ, van der Palen J, Ong F, Riemersma S, Struikmans H. Bilateral breast cancer, synchronous and metachronous; differences and outcome. Breast Cancer Res Treat. 2015;153(2):277\u201383. https:\/\/doi.org\/10.1007\/s10549-015-3538-5.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3214_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21147\/j.issn.1000-9604.2021.01.03","volume":"33","author":"X Li","year":"2021","unstructured":"Li X, Wang Y, Pan B, Li M, Gao J, Zhao Y, et al. Clinical characteristics and clinicopathological correlations of bilateral breast cancer in China: a multicenter study from Chinese Society of Breast Surgery (CSBrS-006). Chin J Cancer Res. 2021;33(1):27\u201332. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2021.01.03.","journal-title":"Chin J Cancer Res"},{"key":"3214_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03528-y","author":"X Wang","year":"2024","unstructured":"Wang X, Wang X, Cai L, Zhang C, Li Y. Clinical characteristics and prognostic analysis of metachronous bilateral breast carcinoma: a retrospective study based on propensity score matching. Clin Transl Oncol. 2024. https:\/\/doi.org\/10.1007\/s12094-024-03528-y.","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"3214_CR28","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1067\/msy.2000.108780","volume":"128","author":"ES Hungness","year":"2000","unstructured":"Hungness ES, Safa M, Shaughnessy EA, Aron BS, Gazder PA, Hawkins HH, et al. Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery. 2000;128(4):702\u20137. https:\/\/doi.org\/10.1067\/msy.2000.108780.","journal-title":"Surgery"},{"issue":"1","key":"3214_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12905-025-03685-4","volume":"25","author":"Q Huang","year":"2025","unstructured":"Huang Q, Lin Q, Yang Y. Trends and survival benefits of bilateral breast-conserving surgery in patients with metachronous bilateral breast cancer. BMC Womens Health. 2025;25(1):152. https:\/\/doi.org\/10.1186\/s12905-025-03685-4.","journal-title":"BMC Womens Health"},{"issue":"3","key":"3214_CR30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s13193-023-01731-x","volume":"14","author":"A Mishra","year":"2023","unstructured":"Mishra A, Oberoi AS, Deo S, Sharma J, Gogia A, Sharma DN, et al. Bilateral breast cancer: clinical profile and management. Indian J Surg Oncol. 2023;14(3):651\u20138. https:\/\/doi.org\/10.1007\/s13193-023-01731-x.","journal-title":"Indian J Surg Oncol"},{"issue":"3","key":"3214_CR31","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1016\/j.clbc.2021.09.009","volume":"22","author":"H Jia","year":"2022","unstructured":"Jia H, Zheng Y, Wang P, Wei Z, Li X, Fu G, et al. A retrospective study on the clinicopathologic characteristics and outcomes of 179 cases of synchronous and metachronous bilateral breast cancer in China. Clin Breast Cancer. 2022;22(3):e341\u20139. https:\/\/doi.org\/10.1016\/j.clbc.2021.09.009.","journal-title":"Clin Breast Cancer"},{"issue":"5","key":"3214_CR32","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/cncr.32618","volume":"126","author":"AW Kurian","year":"2020","unstructured":"Kurian AW, Canchola AJ, Ma CS, Clarke CA, Gomez SL. Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: data from California, 1998 through 2015. Cancer. 2020;126(5):958\u201370. https:\/\/doi.org\/10.1002\/cncr.32618.","journal-title":"Cancer"},{"issue":"2","key":"3214_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2325\/jbcs.12.135","volume":"12","author":"C Yamauchi","year":"2005","unstructured":"Yamauchi C, Mitsumori M, Nagata Y, Kokubo M, Inamoto T, Mise K, et al. Bilateral breast-conserving therapy for bilateral breast cancer: results and consideration of radiation technique. Breast Cancer. 2005;12(2):135\u20139. https:\/\/doi.org\/10.2325\/jbcs.12.135. (PMID: 15858445).","journal-title":"Breast Cancer"},{"issue":"2","key":"3214_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11864-012-0184-6","volume":"13","author":"C Marquette","year":"2012","unstructured":"Marquette C, Nabell L. Chemotherapy-resistant metastatic breast cancer. Curr Treat Options Oncol. 2012;13(2):263\u201375. https:\/\/doi.org\/10.1007\/s11864-012-0184-6.","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"3214_CR35","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1002\/cam4.2198","volume":"8","author":"B Pan","year":"2019","unstructured":"Pan B, Xu Y, Zhou YD, Yao R, Wu HW, Zhu QL, et al. The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: a meta-analysis of studies from recent decade (2008\u20132018). Cancer Med. 2019;8(6):2908\u201318. https:\/\/doi.org\/10.1002\/cam4.2198.","journal-title":"Cancer Med"},{"key":"3214_CR36","doi-asserted-by":"publisher","first-page":"117822342412401","DOI":"10.1177\/11782234241240171","volume":"18","author":"C Aurell","year":"2024","unstructured":"Aurell C, Haidar A, Giglio D. Follow-up routines matter for adherence to endocrine therapy in the adjuvant setting of breast cancer. Breast Cancer (Auckl). 2024;18:11782234241240172. https:\/\/doi.org\/10.1177\/11782234241240171.","journal-title":"Breast Cancer (Auckl)"},{"issue":"Suppl 2","key":"3214_CR37","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1016\/j.breast.2015.07.027","volume":"24","author":"A Mathew","year":"2015","unstructured":"Mathew A, Davidson NE. Adjuvant endocrine therapy for premenopausal women with hormone-responsive breast cancer. Breast. 2015;24(Suppl 2):S120\u20135. https:\/\/doi.org\/10.1016\/j.breast.2015.07.027.","journal-title":"Breast"},{"issue":"2","key":"3214_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cam4.4084","volume":"11","author":"Y Chandler","year":"2022","unstructured":"Chandler Y, Schechter C, Jayasekera J, Isaacs C, Kurian AW, Cadham C, et al. Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics. Cancer Med. 2022;11(2):297\u2013307. https:\/\/doi.org\/10.1002\/cam4.4084.","journal-title":"Cancer Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03214-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03214-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03214-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:57:36Z","timestamp":1759917456000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03214-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3214"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03214-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because SEER uses non-identifiable patient information, institutional review board approval was not required for this research. The right to informed consent was waived because this study was based strictly on the registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The author confirms that the work in question has not been previously published and is not being considered for publication elsewhere, and that the consent to publish has been obtained from all co-authors. Copyright is transferred upon acceptance of the article for publication. The authors warrant that their paper is original and have full authority to give this consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"934"}}